Search

Your search keyword '"Tolosa, C."' showing total 49 results

Search Constraints

Start Over You searched for: Author "Tolosa, C." Remove constraint Author: "Tolosa, C." Topic medicine.disease Remove constraint Topic: medicine.disease
49 results on '"Tolosa, C."'

Search Results

1. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: 'AbSeS', a multinational observational cohort study and ESICM Trials Group Project

2. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

3. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

4. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

5. Predictors of active cancer thromboembolic outcomes

6. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

7. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

8. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

9. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

10. First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort

11. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

12. A TNFSF13B Functional Variant Is Not Involved in Systemic Sclerosis and Giant Cell Arteritis Susceptibility

13. Clinical presentation and outcome of venous thromboembolism in COPD

14. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

15. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

16. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

17. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

18. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

19. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

20. Platelet count and outcome in patients with acute venous thromboembolism

21. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

22. Unsuspected pulmonary embolism in patients with cancer

23. Usefulness of Thrombophilia Testing in Venous Thromboembolic Disease

24. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism

25. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry

26. A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis

27. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

28. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry

29. Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism

30. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer

31. Influence of recent immobilization and recent surgery on mortality in patients with pulmonary embolism

32. Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function

33. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

34. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs

35. Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

36. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry

37. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor

38. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis

39. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

40. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

41. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

42. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

43. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

44. Timing and characteristics of venous thromboembolism after noncancer surgery

45. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

46. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

47. DVT Management and Outcome Trends, 2001 to 2014

48. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

49. Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients

Catalog

Books, media, physical & digital resources